Full description
This entry contains the primary datasets related to the Thesis - Clarifying the role of phamracological factors in the pathogenesis of statin-associated muscle symptoms and the ability of geranylgeranyl pyrophosphate to prevent statin-induced muscle fatigueIssued: 2019-11-04
Created: 2021-04-16
Subjects
Clinical Pharmacology and Therapeutics |
Dose |
Geranylgeranyl pyrophosphate (GGPP) |
Statin-associated muscle symptoms (SAMS) |
Statin-induced myotoxicity |
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover